FDA warned HomeoAnimal that it sells unapproved animal drugs with claims to treat cancer, heartworm, seizures, and COVID-19 in animals.
What happened
FDA reviewed HomeoAnimal’s website from December 2020 through March 2021 and its Facebook page. FDA found the company took orders for many animal products and claimed they cure, mitigate, treat, or prevent diseases in animals, including coronavirus/COVID-19 claims for a Virus Defense Kit. FDA said these products are unapproved new animal drugs, meaning drugs that need FDA approval before they can be sold.
What FDA found
The website claims the products treat or prevent diseases in animals, which makes them drugs under the law.
FD&C Act section 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]The products are new animal drugs because they are not generally recognized as safe and effective for their labeled uses.
FD&C Act section 201(v) [21 U.S.C. § 321(v)]The products are not FDA-approved or index listed, so FDA considers them unsafe.
FD&C Act section 512(a) [21 U.S.C. § 360b(a)]Because they are unapproved, FDA calls the products adulterated.
FD&C Act section 501(a)(5) [21 U.S.C. § 351(a)(5)]Selling or shipping these products in interstate commerce is prohibited.
FD&C Act section 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA tells HomeoAnimal to take immediate action to stop selling unapproved products that claim to mitigate, prevent, treat, diagnose, or cure COVID-19. The company must notify FDA in writing within 15 working days of steps taken to correct the violations, or explain any delay and give a completion date.
Who should pay attention
- veterinarians and pet owners who buy online animal remedies
- animal supplement and homeopathic product sellers making disease claims
- online marketplaces and social media platforms hosting such claims
This is a summary. Read the original letter on fda.gov.